100
Participants
Start Date
May 19, 2025
Primary Completion Date
November 24, 2026
Study Completion Date
December 1, 2026
Patient-tailored deprescribing assessment and intervention
Patients are identified for enrollment via a risk prediction model and enrolled in a pharmacist-led polypharmacy clinic. The pharmacist will conduct a comprehensive medication review, which will include: medication reconciliation, assessment of patient risk factors (clinical, socioeconomic), identification of potentially inappropriate medications, identification of potential prescribing omissions, shared decision-making with the patient and/or caregiver, and confirmation of the results of the comprehensive medication review with the primary care clinician. Once the primary care clinician has approved the recommendations, the pharmacist will make the appropriate changes to the medication regimen, will provide tailored medication education and counseling (including Motivational Interviewing) and will follow-up with the patient at least once per month via video visit or phone to assess side effects, adverse effects, and provide support.
Cedars-Sinai Medical Center, Los Angeles
National Institute on Aging (NIA)
NIH
Cedars-Sinai Medical Center
OTHER